Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Clinical trial NCT00787566 · COMPLETED

Trial details

NCT number: NCT00787566
Sponsor: Shin Nippon Biomedical Laboratories, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting

Start date: 2008-10-01
Primary completion: 2009-04-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.